Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Vascular Health and Risk Management · 2024-05 · Volume 20 · 231-244
DOI: 10.2147/vhrm.s455530 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Vascular Health and Risk Management, 2024-05. Verfasst von Soonil Kwon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Factor Xa Inhibitors, Perioperative Care, Registries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Chest & Heart Hospital, Liverpool, UK.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: So-Ryoung Lee, Eue-Keun Choi
Zitieren
APA
Kwon, S., Lee, S. R., Choi, E. K., Lee, K. Y., Choi, J., Ahn, H. J., Oh, S., & Lip, G. Y. H. (2024). Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study. Vascular Health and Risk Management, Volume 20, 231-244. https://doi.org/10.2147/vhrm.s455530
Vancouver
Kwon S, Lee SR, Choi EK, Lee KY, Choi J, Ahn HJ, et al. Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study. Vascular Health and Risk Management. 2024;Volume 20:231-244. doi:10.2147/vhrm.s455530
BibTeX
@article{Kwon2024,
author = {Kwon, Soonil and Lee, So-Ryoung and Choi, Eue-Keun and Lee, Kyung-Yeon and Choi, JungMin and Ahn, Hyo-Jeong and Oh, Seil and Lip, Gregory Yoke Hong},
title = {Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study},
journal = {Vascular Health and Risk Management},
year = {2024},
volume = {Volume 20},
pages = {231--244},
doi = {10.2147/vhrm.s455530}
}
EUVIMED